Economic evaluation of home blood pressure telemonitoring: a randomized controlled trial.

Aims: The purpose of the present study was to compare the costs of home blood pressure (BP) telemonitoring (HBPM) with the costs of conventional office BP monitoring. In a randomized controlled trial, 105 hypertensive patients performed HBPM and 118 patients received usual care with conventional office BP monitoring during 6 months. Costs were quantified from the healthcare perspective.

Health-related quality of life (SF-36) during telemonitoring of home blood pressure in hypertensive patients: a randomized, controlled study.

Telemonitoring of home blood pressure (BP) is a new advance in home BP monitoring (HBPM) and has proved effective in improving BP control. The impact of telemedical HBPM on health-related quality of life (HRQOL) has not yet been studied. The purpose of this study is to compare HRQOL using a generic scale (SF-36) in patients with antihypertensive treatment based on telemedical HBPM and in patients with antihypertensive treatment based on conventional monitoring of office BP.

Blood pressure control during telemonitoring of home blood pressure. A randomized controlled trial during 6 months.

Aim: To compare the effectiveness of antihypertensive treatment based on telemonitoring of home blood pressure (BP) and conventional monitoring of office BP.

Methods: Hypertensive patients (n = 236) participated in a randomized, controlled study. In the intervention group, antihypertensive treatment was based on home BP monitoring.